114 related articles for article (PubMed ID: 36271565)
1. Patterns of immune infiltration and survival in endocrine therapy-treated ER-positive breast cancer: A computational study of 1900 patients.
Wang WQ; Zhang L; Yang F; Zhou HH; Zhang W; Zou Y; Liu R
Biomed Pharmacother; 2022 Nov; 155():113787. PubMed ID: 36271565
[TBL] [Abstract][Full Text] [Related]
2. Influence of Tumor Immune Infiltration on Immune Checkpoint Inhibitor Therapeutic Efficacy: A Computational Retrospective Study.
Liu R; Yang F; Yin JY; Liu YZ; Zhang W; Zhou HH
Front Immunol; 2021; 12():685370. PubMed ID: 34220837
[TBL] [Abstract][Full Text] [Related]
3. Regulatory T lymphocyte infiltration in metastatic breast cancer-an independent prognostic factor that changes with tumor progression.
Stenström J; Hedenfalk I; Hagerling C
Breast Cancer Res; 2021 Feb; 23(1):27. PubMed ID: 33602289
[TBL] [Abstract][Full Text] [Related]
4. Elevated expression of FREM1 in breast cancer indicates favorable prognosis and high-level immune infiltration status.
Li HN; Li XR; Lv ZT; Cai MM; Wang G; Yang ZF
Cancer Med; 2020 Dec; 9(24):9554-9570. PubMed ID: 33058542
[TBL] [Abstract][Full Text] [Related]
5. The establishment of immune infiltration based novel recurrence predicting nomogram in prostate cancer.
Meng J; Liu Y; Guan S; Fan S; Zhou J; Zhang M; Liang C
Cancer Med; 2019 Sep; 8(11):5202-5213. PubMed ID: 31355524
[TBL] [Abstract][Full Text] [Related]
6. A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer.
Bonneau C; Eliès A; Kieffer Y; Bourachot B; Ladoire S; Pelon F; Hequet D; Guinebretière JM; Blanchet C; Vincent-Salomon A; Rouzier R; Mechta-Grigoriou F
Breast Cancer Res; 2020 Jul; 22(1):76. PubMed ID: 32665033
[TBL] [Abstract][Full Text] [Related]
7. Clinical Implications of Tumor-Infiltrating Immune Cells in Breast Cancer.
Zhang SC; Hu ZQ; Long JH; Zhu GM; Wang Y; Jia Y; Zhou J; Ouyang Y; Zeng Z
J Cancer; 2019; 10(24):6175-6184. PubMed ID: 31762828
[TBL] [Abstract][Full Text] [Related]
8. In silico analysis of the immune microenvironment in bladder cancer.
Zhang Y; Ou DH; Zhuang DW; Zheng ZF; Lin ME
BMC Cancer; 2020 Mar; 20(1):265. PubMed ID: 32228629
[TBL] [Abstract][Full Text] [Related]
9. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
10. Tumour-Infiltrating Inflammatory Cells in Early Breast Cancer: An Underrated Prognostic and Predictive Factor?
Schnellhardt S; Erber R; Büttner-Herold M; Rosahl MC; Ott OJ; Strnad V; Beckmann MW; King L; Hartmann A; Fietkau R; Distel L
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153211
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analyses of the heterogeneity and prognostic significance of tumor-infiltrating immune cells in non-small-cell lung cancer: Development and validation of an individualized prognostic model.
Pang Z; Chen X; Wang Y; Wang Y; Yan T; Wan J; Du J
Int Immunopharmacol; 2020 Sep; 86():106744. PubMed ID: 32623229
[TBL] [Abstract][Full Text] [Related]
12. Analysis of genomics and immune infiltration patterns of epithelial-mesenchymal transition related to metastatic breast cancer to bone.
Liu S; Song A; Wu Y; Yao S; Wang M; Niu T; Gao C; Li Z; Zhou X; Huo Z; Yang B; Liu Y; Wang Y
Transl Oncol; 2021 Feb; 14(2):100993. PubMed ID: 33333372
[TBL] [Abstract][Full Text] [Related]
13. Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer.
Ino Y; Yamazaki-Itoh R; Shimada K; Iwasaki M; Kosuge T; Kanai Y; Hiraoka N
Br J Cancer; 2013 Mar; 108(4):914-23. PubMed ID: 23385730
[TBL] [Abstract][Full Text] [Related]
14. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K
Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441
[TBL] [Abstract][Full Text] [Related]
15. Identification of three molecular subtypes based on immune infiltration in ovarian cancer and its prognostic value.
Liu J; Tan Z; He J; Jin T; Han Y; Hu L; Song J; Huang S
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33043974
[TBL] [Abstract][Full Text] [Related]
16. An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer.
Sui S; An X; Xu C; Li Z; Hua Y; Huang G; Sui S; Long Q; Sui Y; Xiong Y; Ntim M; Guo W; Chen M; Deng W; Xiao X; Li M
Theranostics; 2020; 10(26):11938-11949. PubMed ID: 33204321
[No Abstract] [Full Text] [Related]
17. Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study.
Ali HR; Chlon L; Pharoah PD; Markowetz F; Caldas C
PLoS Med; 2016 Dec; 13(12):e1002194. PubMed ID: 27959923
[TBL] [Abstract][Full Text] [Related]
18. [Establishment of a prediction model for colorectal cancer immune cell infiltration based on the cancer genome atlas (TCGA) database].
Ding TT; Zeng CX; Hu LN; Yu MH
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 54(2):203-208. PubMed ID: 35435180
[TBL] [Abstract][Full Text] [Related]
19. Immune cell analyses of the tumor microenvironment in prostate cancer highlight infiltrating regulatory T cells and macrophages as adverse prognostic factors.
Andersen LB; Nørgaard M; Rasmussen M; Fredsøe J; Borre M; Ulhøi BP; Sørensen KD
J Pathol; 2021 Oct; 255(2):155-165. PubMed ID: 34255349
[TBL] [Abstract][Full Text] [Related]
20. Identification of DRP1 as a prognostic factor correlated with immune infiltration in breast cancer.
Liu B; Fan Y; Song Z; Han B; Meng Y; Cao P; Tan K
Int Immunopharmacol; 2020 Dec; 89(Pt B):107078. PubMed ID: 33049497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
